Valiant Organics Reports Strong Q3FY26 Results with ₹606.36 Lakhs Net Profit

2 min read     Updated on 13 Feb 2026, 11:12 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Valiant Organics Limited announced strong Q3FY26 results with net profit of ₹606.36 lakhs, representing 30.52% growth despite revenue decline. The company achieved remarkable nine-month turnaround with ₹1,923.82 lakhs profit versus previous year's loss, aided by ₹572.08 lakhs exceptional gain from fire insurance settlement.

32170000

*this image is generated using AI for illustrative purposes only.

Valiant Organics Limited announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, following the Board of Directors meeting held on February 13, 2026. The company reported a net profit of ₹606.36 lakhs for Q3FY26, marking a significant improvement of 30.52% from ₹464.60 lakhs in the corresponding quarter of the previous year.

Financial Performance Overview

The company's standalone financial results demonstrate mixed operational performance during the quarter. While revenue from operations declined to ₹15,906.97 lakhs in Q3FY26 from ₹18,685.71 lakhs in Q3FY25, the company achieved improved profitability through better cost management and exceptional gains.

Financial Metric: Q3FY26 Q3FY25 Change (%)
Revenue from Operations: ₹15,906.97 lakhs ₹18,685.71 lakhs -14.87%
Net Profit: ₹606.36 lakhs ₹464.60 lakhs +30.52%
Basic EPS: ₹2.16 ₹1.18 +83.05%
Total Income: ₹16,070.56 lakhs ₹19,190.05 lakhs -16.26%

Nine Months Performance Turnaround

For the nine months ended December 31, 2025, the company achieved a remarkable turnaround with net profit of ₹1,923.82 lakhs compared to a net loss of ₹695.44 lakhs in the corresponding period of the previous year. This represents a complete reversal of fortunes for the chemical manufacturer.

Nine Months Metric: FY26 (9M) FY25 (9M) Performance
Revenue from Operations: ₹52,068.29 lakhs ₹51,494.99 lakhs +1.11%
Net Profit/(Loss): ₹1,923.82 lakhs (₹695.44 lakhs) Positive turnaround
Basic EPS: ₹6.87 (₹3.35) Significant improvement
Total Income: ₹52,358.81 lakhs ₹52,239.52 lakhs +0.23%

Exceptional Items and Insurance Settlement

A significant highlight of the quarter was the recognition of exceptional gain of ₹572.08 lakhs. The company received ₹852.76 lakhs towards fire insurance claim settlement relating to the Sarigam Division fire incident from FY 2022-23. Out of this amount, ₹572.08 lakhs was recognized under exceptional items during the period, with the balance appropriately accounted for in the financial statements.

Consolidated Results and Corporate Actions

The consolidated results showed net profit of ₹364.45 lakhs for Q3FY26 compared to ₹546.41 lakhs in Q3FY25. For nine months, consolidated net profit reached ₹1,750.92 lakhs against a loss of ₹762.46 lakhs in the previous year.

Corporate Development: Details
Employee Stock Options: 15,000 shares allotted on November 29, 2025
Stock Options Granted: 15,000 (May 22, 2025) and 1,000 (November 13, 2025)
Paid-up Equity Capital: ₹2,801.96 lakhs (face value ₹10 each)
Board Meeting Duration: 12:45 PM to 4:02 PM IST

The Board meeting commenced at 12:45 PM IST and concluded at 4:02 PM IST on February 13, 2026. The company operates as a single segment engaged in manufacturing chemicals business and has fulfilled its regulatory obligations under Regulation 33 and 30 of the SEBI Listing Regulations.

Historical Stock Returns for Valiant Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-6.09%+21.76%+2.68%-31.76%+1.06%-79.50%

Valiant Organics Shareholders Approve Key Appointments and Secretarial Auditor at 20th AGM

2 min read     Updated on 26 Sept 2025, 05:43 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Valiant Organics Limited held its 20th AGM on September 26, approving several important resolutions. Shareholders re-appointed Shri Mahek M. Chheda as Executive Director and Shri Kiritkumar H. Desai as Non-Executive Director. M/s Mehta & Mehta was appointed as the new Secretarial Auditor for five years. The company reported an operating revenue of 719.00 crore for FY 2024-25 with an EBITDA margin of 7.47%. Other approvals included remuneration for the Managing Director and Cost Auditor, and material related party transactions.

20434391

*this image is generated using AI for illustrative purposes only.

Valiant Organics Limited, a leading manufacturer of specialty chemicals, held its 20th Annual General Meeting (AGM) on September 26, where shareholders approved several important resolutions, including key appointments and the selection of a new secretarial auditor.

Director Re-appointments

The shareholders re-appointed two directors to the company's board:

  1. Shri Mahek M. Chheda was re-appointed as an Executive Director. With over eight years of experience, Chheda brings expertise in finance, marketing, human resources, and business development to the company.

  2. Shri Kiritkumar H. Desai was re-appointed as a Non-Executive Director. Desai boasts an impressive 32-year career in research and development and quality control within the chemical and pharmaceutical industries. His experience includes developing more than 200 products.

Both directors will be liable to retire by rotation, as per the company's articles.

New Secretarial Auditor

In a move to enhance corporate governance, the shareholders approved the appointment of M/s Mehta & Mehta as the company's Secretarial Auditor. The firm will serve for five consecutive years, from the financial year 2025-26 to 2029-30. M/s Mehta & Mehta brings over 25 years of experience in legal and secretarial consultancy services to Valiant Organics.

Other Key Developments

The AGM, conducted through video conferencing and other audio-visual means, also addressed several other important matters:

  • The company presented its audited financial statements for the year ended March 31.
  • Shareholders approved the remuneration for Shri Sathiababu K. Kallada, Managing Director of the company.
  • Material related party transactions with several entities, including Aarti Industries Limited and Valiant Laboratories Limited, were approved.
  • The remuneration for the Cost Auditor for the financial year 2025-26 was ratified.

Financial Highlights

During the meeting, the company's Executive Director and Chief Financial Officer, Shri Mahek M. Chheda, presented an overview of Valiant Organics' financial performance:

Metric Value
Operating Revenue for FY 2024-25 719.00 crore
EBITDA Margin for FY 2024-25 7.47%
Net Worth as of March 31 570.00 crore

Company Overview

Valiant Organics Limited, incorporated in 1984, is a specialty chemicals manufacturer headquartered in Mumbai, India. The company focuses on producing chemicals for various industries, including agrochemicals, pharmaceuticals, dyes, and pigments. With six manufacturing units across five locations and a total production capacity of 70,000 TPA, Valiant Organics has established itself as a significant player in the chlorophenol derivatives and PNA manufacturing sectors.

The AGM concluded with a Q&A session where shareholders had the opportunity to engage with the management on various aspects of the company's operations and future strategies.

As Valiant Organics moves forward with its newly appointed leadership and auditor, the company aims to strengthen its position in the specialty chemicals market while maintaining its commitment to quality and growth.

Historical Stock Returns for Valiant Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-6.09%+21.76%+2.68%-31.76%+1.06%-79.50%

More News on Valiant Organics

1 Year Returns:+1.06%